A new chitosan-based thermosensitive nanoplatform for combined photothermal and chemotherapy

Int J Biol Macromol. 2022 Dec 31;223(Pt A):1356-1367. doi: 10.1016/j.ijbiomac.2022.11.068. Epub 2022 Nov 13.

Abstract

Targeting the delivery of anti-cancer drugs to a tumor site is essential for effective treatment and to ensure minimal damage to healthy cells and tissues. In this work, a chitosan-based nanoplatform was constructed for combined photothermal therapy and chemotherapy of breast cancer. The pH-sensitive and biocompatible biopolymer chitosan (CS) was grafted with N-vinylcaprolactam (NVCL) and modified with biotin (Bio), imparting it with temperature sensitive property and also the ability for active targeting. The polymer self-assembled to give nanoparticles (NPs) loaded with indocyanine green (ICG) and doxorubicin (DOX). When the NPs are exposed to near-infrared (NIR) laser irradiation, ICG converts the light to heat, inducing a significant phase transition in the NPs and facilitating the release of the drug cargo. In addition, the solubility of chitosan is increased in the slightly acidic microenvironment of the tumor site, which also promotes drug release. A detailed analysis of the NPs both in vitro and in vivo showed that the carrier system is biocompatible, while the drug-loaded NPs are selectively taken up by cancer cells. Particularly when augmented with NIR irradiation, this leads to potent cell death in vitro and also in an in vivo murine xenograft model of breast cancer.

Keywords: Chitosan; Photothermal therapy; Thermosensitive material.

MeSH terms

  • Animals
  • Breast Neoplasms* / drug therapy
  • Cell Line, Tumor
  • Chitosan*
  • Doxorubicin / pharmacology
  • Drug Delivery Systems
  • Female
  • Humans
  • Indocyanine Green / pharmacology
  • Mice
  • Nanoparticles*
  • Tumor Microenvironment

Substances

  • Chitosan
  • Doxorubicin
  • Indocyanine Green